- Home
- ALGS vs NYC Comparison
ALGS vs NYC Comparison
Compare ALGS & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- NYC
- Stock Information
- Founded
- ALGS 2018
- NYC 2013
- Country
- ALGS United States
- NYC United States
- Employees
- ALGS N/A
- NYC N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- NYC Real Estate
- Sector
- ALGS Health Care
- NYC Finance
- Exchange
- ALGS Nasdaq
- NYC Nasdaq
- Market Cap
- ALGS 36.0M
- NYC 27.8M
- IPO Year
- ALGS 2020
- NYC N/A
- Fundamental
- Price
- ALGS $5.29
- NYC $9.66
- Analyst Decision
- ALGS Strong Buy
- NYC
- Analyst Count
- ALGS 1
- NYC 0
- Target Price
- ALGS $70.00
- NYC N/A
- AVG Volume (30 Days)
- ALGS 163.7K
- NYC 2.6K
- Earning Date
- ALGS 05-06-2025
- NYC 05-09-2025
- Dividend Yield
- ALGS N/A
- NYC N/A
- EPS Growth
- ALGS N/A
- NYC N/A
- EPS
- ALGS N/A
- NYC N/A
- Revenue
- ALGS $3,270,000.00
- NYC $58,397,000.00
- Revenue This Year
- ALGS N/A
- NYC $8.40
- Revenue Next Year
- ALGS N/A
- NYC $1.62
- P/E Ratio
- ALGS N/A
- NYC N/A
- Revenue Growth
- ALGS N/A
- NYC N/A
- 52 Week Low
- ALGS $3.76
- NYC $7.55
- 52 Week High
- ALGS $46.80
- NYC $13.59
- Technical
- Relative Strength Index (RSI)
- ALGS 43.20
- NYC 35.90
- Support Level
- ALGS $5.47
- NYC $9.38
- Resistance Level
- ALGS $6.12
- NYC $11.29
- Average True Range (ATR)
- ALGS 0.60
- NYC 0.63
- MACD
- ALGS 0.12
- NYC -0.13
- Stochastic Oscillator
- ALGS 37.30
- NYC 11.87
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.